Sandoz Australia & New Zealand is an affiliate of Sandoz AG (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure more than 900 million patient treatments are provided by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Company Details
- Employees
- 73
- Address
- North Sydney , New South Wales 2060, Au
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.sandoz.com.au
- Keywords
- 🏅.
- HQ
- North Sydney , New South Wales
Sandoz Australia & New Zealand Questions
Sandoz Australia & New Zealand's website is http://www.sandoz.com.au
Sandoz Australia & New Zealand's LinkedIn profile is https://au.linkedin.com/company/sandoz-aunz
Sandoz Australia & New Zealand has
73 employees.
View email and phone details for 73
employees at Sandoz Australia & New Zealand.
Sandoz Australia & New Zealand's industry is
Pharmaceutical Manufacturing
Sandoz Australia & New Zealand's top competitors are
Novo Nordisk,
Msd Australia & New Zealand,
Pfizer,
Viatris,
Arrotex Pharmaceuticals,
Sandoz Asia Cluster,
Novartis, Australia & New Zealand,
Sandoz,
Novartis,
Eli Lilly And Company.
Sandoz Australia & New Zealand's categories are Pharmaceutical Manufacturing
